Spain· ES:1221653001
UPSTAZA 2,8 × 10E11 GENOMAS VECTORIALES (VG)/0,5 ML PARA SOLUCION PARA PERFUSION
A medicinal product containing eladocagén exuparvovec, registered in Spain by Ptc Therapeutics International Limited.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- eladocagén exuparvovec
- Manufacturer
- Ptc Therapeutics International Limited
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- June 3, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Eladocagén exuparvovec in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesKEBILIDIPTC Therapeutics, Inc.
- CzechiaUPSTAZAPTC Therapeutics International Limited, Dublin 2
- FinlandUpstazaPTC Therapeutics International limited
- FranceUPSTAZA 2,8 x 100 000 000 000 génomes de vecteur (vg)/0,5 mL, solution pour perfusionPTC THERAPEUTICS INTERNATIONAL (IRLANDE)
- United KingdomUpstaza 280 giga vector genomes/0.5ml solution for infusion vialsPTC Therapeutics Ltd
- BelgiumUpstaza 2.8 10*11 vg/0.5 mlPTC Therapeutics International
- IcelandUpstazaPTC Therapeutics International Limited*
- NetherlandsUpstaza 2,8 x 10^11 vg/0.5 ml, oplossing voor infusiePTC Therapeutics International Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Upstaza
- Liechtenstein · Upstaza
- Norway · Upstaza
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3982579f-36e6-4c3d-b094-bc7bd379badc GET /v1/drugs/3982579f-36e6-4c3d-b094-bc7bd379badc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Uso Hospitalario",
"estado": "{\"aut\":1671711974000}",
"nregistro": "1221653001",
"substance": "eladocagén exuparvovec"
}See everything about eladocagén exuparvovec.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.